# BOSUTINIB
> **ANDA209577** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDUSTRIES · Approved 2023-08-25
## Drug
- **FDA Application Number:** ANDA209577
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BOSUTINIB
- **Generic name:** Bosutinib Monohydrate
- **Active ingredients:** BOSUTINIB MONOHYDRATE
- **Dosage form:** TABLET
- **Route:** FILM COATED
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SUN PHARM INDUSTRIES
- **First approval:** 2023-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209577)
---
*MORVS · CC0 1.0*